Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Oil & Gas, Telecoms and Basic Materials sectors led shares higher. At the close in NYSE, the...
Catalent (NYSE:CTLT) reported Q3 EPS of $1.04, $0.10 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of...
Investing.com – U.S. stocks were lower after the close on Tuesday, as losses in the Healthcare, Financials and Technology sectors led shares lower. At the close in NYSE, the Dow...
Shares of McKesson Corporation (NYSE:MCK) MCK scaled a new 52-week high of $258.28 on Jan 28, before closing the session marginally lower at $258.21.Over the past year, this Zacks...
Masimo (NASDAQ:MASI) Corporation MASI announced preliminary financial results for full-year 2021 on Jan 11. Following this release, shares of the company are down 0.5% till the...
Moderna (NASDAQ:MRNA), Inc. MRNA and the newly founded manufacturing and technology company, National Resilience, Inc. (Resilience), signed a multi-year agreement for manufacturing...
Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Sell | Sell | Strong Sell | Neutral |
| Technical Indicators | Buy | Sell | Strong Sell | Sell | Strong Sell |
| Summary | Buy | Sell | Strong Sell | Strong Sell | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 82.47 | 85.12 | 81.54 | -4.76 | -5.46% | 15.11M | NYSE | |||
| 8.24 | 8.39 | 8.00 | -0.00 | -0.05% | 6.20M | NYSE | |||
| 38.76 | 39.12 | 38.31 | -0.66 | -1.67% | 7.42M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 0.208 | 0.208 | 0.183 | +0.0250 | +13.66% | 1.29M | NYSE | |||
| 1.13 | 1.135 | 1.09 | -0.0300 | -2.59% | 5.36M | NYSE | |||
| 100.49 | 101.22 | 99.17 | -0.29 | -0.29% | 965.41K | NYSE | |||
| 10.33 | 10.66 | 9.95 | -0.28 | -2.64% | 377.50K | NASDAQ | |||
| 28.70 | 28.75 | 28.28 | +0.34 | +1.20% | 204.04K | NYSE | |||
| 29.17 | 29.50 | 28.91 | -0.72 | -2.41% | 125.45K | OTC Markets | |||
| 0.0018 | 0.0019 | 0.0018 | 0.0000 | 0.00% | 0.00 | OTC Markets | |||
| 3.85 | 3.85 | 3.79 | 0.000 | 0.00% | 1.14M | NYSE | |||
| 20.86 | 21.46 | 20.58 | -0.70 | -3.25% | 249.69K | NASDAQ | |||
| 9.64 | 9.64 | 9.64 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 23.30 | 23.80 | 23.23 | 0.00 | 0.00% | 0.00 | NASDAQ |